196 related articles for article (PubMed ID: 33538531)
1. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System.
Zhang C; Jin DD; Wang XY; Lou L; Yang J
J Cardiovasc Pharmacol; 2021 Feb; 77(2):142-152. PubMed ID: 33538531
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate Cascade and its Regulation in Cholesterol Metabolism in Different Tissues in Health and Disease.
Hashemi M; Hoshyar R; Ande SR; Chen QM; Solomon C; Zuse A; Naderi M
Curr Mol Pharmacol; 2017; 10(1):13-26. PubMed ID: 26758949
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of farnesyl pyrophosphate (FPP) and/or geranylgeranyl pyrophosphate (GGPP) biosynthesis and its implication in the treatment of cancers.
Waller DD; Park J; Tsantrizos YS
Crit Rev Biochem Mol Biol; 2019 Feb; 54(1):41-60. PubMed ID: 30773935
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients.
Eckert GP; Hooff GP; Strandjord DM; Igbavboa U; Volmer DA; Müller WE; Wood WG
Neurobiol Dis; 2009 Aug; 35(2):251-7. PubMed ID: 19464372
[TBL] [Abstract][Full Text] [Related]
5. Isoprenoids, small GTPases and Alzheimer's disease.
Hooff GP; Wood WG; Müller WE; Eckert GP
Biochim Biophys Acta; 2010 Aug; 1801(8):896-905. PubMed ID: 20382260
[TBL] [Abstract][Full Text] [Related]
6. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
[TBL] [Abstract][Full Text] [Related]
7. Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.
Chen B; Zhong LY; Yang JX; Pan YY; Chen F; Yang J; Wu T; Hu SJ
Cell Physiol Biochem; 2013; 32(6):1761-75. PubMed ID: 24356578
[TBL] [Abstract][Full Text] [Related]
8. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
9. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cholesterol, farnesylpyrophosphate, and geranylgeranylpyrophosphate in neuroblastoma SH-SY5Y-APP695 cells: impact on amyloid beta-protein production.
Hooff GP; Peters I; Wood WG; Müller WE; Eckert GP
Mol Neurobiol; 2010 Jun; 41(2-3):341-50. PubMed ID: 20405344
[TBL] [Abstract][Full Text] [Related]
11. Isoprenoids and tau pathology in sporadic Alzheimer's disease.
Pelleieux S; Picard C; Lamarre-Théroux L; Dea D; Leduc V; Tsantrizos YS; Poirier J
Neurobiol Aging; 2018 May; 65():132-139. PubMed ID: 29476987
[TBL] [Abstract][Full Text] [Related]
12. Human farnesyl pyrophosphate synthase is allosterically inhibited by its own product.
Park J; Zielinski M; Magder A; Tsantrizos YS; Berghuis AM
Nat Commun; 2017 Jan; 8():14132. PubMed ID: 28098152
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeranyl-pyrophosphate, an isoprenoid of mevalonate cascade, is a critical compound for rat primary cultured cortical neurons to protect the cell death induced by 3-hydroxy-3-methylglutaryl-CoA reductase inhibition.
Tanaka T; Tatsuno I; Uchida D; Moroo I; Morio H; Nakamura S; Noguchi Y; Yasuda T; Kitagawa M; Saito Y; Hirai A
J Neurosci; 2000 Apr; 20(8):2852-9. PubMed ID: 10751437
[TBL] [Abstract][Full Text] [Related]
14. Alteration of enzyme expressions in mevalonate pathway: possible role for cardiovascular remodeling in spontaneously hypertensive rats.
Han J; Jiang DM; Du CQ; Hu SJ
Circ J; 2011; 75(6):1409-17. PubMed ID: 21467659
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer therapy: targeting the mevalonate pathway.
Swanson KM; Hohl RJ
Curr Cancer Drug Targets; 2006 Feb; 6(1):15-37. PubMed ID: 16475974
[TBL] [Abstract][Full Text] [Related]
16. Isoprenoids influence expression of Ras and Ras-related proteins.
Holstein SA; Wohlford-Lenane CL; Hohl RJ
Biochemistry; 2002 Nov; 41(46):13698-704. PubMed ID: 12427032
[TBL] [Abstract][Full Text] [Related]
17. Brain isoprenoids farnesyl pyrophosphate and geranylgeranyl pyrophosphate are increased in aged mice.
Hooff GP; Wood WG; Kim JH; Igbavboa U; Ong WY; Muller WE; Eckert GP
Mol Neurobiol; 2012 Aug; 46(1):179-85. PubMed ID: 22692983
[TBL] [Abstract][Full Text] [Related]
18. Regulation of fatty acid synthesis by farnesyl pyrophosphate.
Murthy S; Tong H; Hohl RJ
J Biol Chem; 2005 Dec; 280(51):41793-804. PubMed ID: 16221687
[TBL] [Abstract][Full Text] [Related]
19. Targeting the mevalonate cascade as a new therapeutic approach in heart disease, cancer and pulmonary disease.
Yeganeh B; Wiechec E; Ande SR; Sharma P; Moghadam AR; Post M; Freed DH; Hashemi M; Shojaei S; Zeki AA; Ghavami S
Pharmacol Ther; 2014 Jul; 143(1):87-110. PubMed ID: 24582968
[TBL] [Abstract][Full Text] [Related]
20. A highly conserved signal controls degradation of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in eukaryotes.
Gardner RG; Hampton RY
J Biol Chem; 1999 Oct; 274(44):31671-8. PubMed ID: 10531376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]